Deriving Convergent and Divergent Metabolomic Correlates of Pulmonary Arterial Hypertension
Metabolites · 28.06.2023 · 13 (7) · 802
DOI: 10.3390/metabo13070802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Metabolites, online erschienen am 28.06.2023. Verfasst von Mona Alotaibi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA 92093, USA. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NHLBI NIH HHS, NIH HHS.
Abstract (Originalsprache)
High-dimensional metabolomics analyses may identify convergent and divergent markers, potentially representing aligned or orthogonal disease pathways that underly conditions such as pulmonary arterial hypertension (PAH). Using a comprehensive PAH metabolomics dataset, we applied six different conventional and statistical learning techniques to identify analytes associated with key outcomes and compared the results. We found that certain conventional techniques, such as Bonferroni/FDR correction, prioritized metabolites that tended to be highly intercorrelated. Statistical learning techniques generally agreed with conventional techniques on the top-ranked metabolites, but were also more inclusive of different metabolite groups. In particular, conventional methods prioritized sterol and oxylipin metabolites in relation to idiopathic versus non-idiopathic PAH, whereas statistical learning methods tended to prioritize eicosanoid, bile acid, fatty acid, and fatty acyl ester metabolites. Our findings demonstrate how conventional and statistical learning techniques can offer both concordant or discordant results. In the case of a rare yet morbid condition, such as PAH, convergent metabolites may reflect common pathways to shared disease outcomes whereas divergent metabolites could signal either distinct etiologic mechanisms, different sub-phenotypes, or varying stages of disease progression. Notwithstanding the need to investigate the mechanisms underlying the observed results, our main findings suggest that a multi-method approach to statistical analyses of high-dimensional human metabolomics datasets could effectively broaden the scientific yield from a given study design.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary, Critical Care and Sleep Medicine, University of California San Diego, La Jolla, CA 92093, USA.
- Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Department of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA.
- Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
- Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.
ORCID-Profile: Alan C Kwan, Susan Cheng
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- NIH HHS
- NCI NIH HHS
- National Institutes of Health (NIH)
Zitieren
APA
Alotaibi, M., Liu, Y., Magalang, G. A., Kwan, A. C., Ebinger, J. E., Nichols, W. C., Pauciulo, M. W., Jain, M., & Cheng, S. (2023). Deriving Convergent and Divergent Metabolomic Correlates of Pulmonary Arterial Hypertension. Metabolites, 13(7), 802. https://doi.org/10.3390/metabo13070802
Vancouver
Alotaibi M, Liu Y, Magalang GA, Kwan AC, Ebinger JE, Nichols WC, et al. Deriving Convergent and Divergent Metabolomic Correlates of Pulmonary Arterial Hypertension. Metabolites. 2023;13(7):802. doi:10.3390/metabo13070802
BibTeX
@article{Alotaibi2023,
author = {Alotaibi, Mona and Liu, Yunxian and Magalang, Gino A and Kwan, Alan C and Ebinger, Joseph E and Nichols, William C and Pauciulo, Michael W and Jain, Mohit and Cheng, Susan},
title = {Deriving Convergent and Divergent Metabolomic Correlates of Pulmonary Arterial Hypertension},
journal = {Metabolites},
year = {2023},
volume = {13},
number = {7},
pages = {802},
doi = {10.3390/metabo13070802}
}
EUVIMED